Skip to main content
. 2016 Oct 4;11(10):e0163264. doi: 10.1371/journal.pone.0163264

Fig 2. (A) Cumulative disease-free survival (DFS) and (B) overall survival (OS) rates of the 298 colorectal cancer patients calculated using the Kaplan—Meier method.

Fig 2

Positive biochip results correlated strongly with lower DFS and OS rates of colorectal cancer patients (both P < 0.001).